Last reviewed · How we verify
uric-acid-lowering drug
At a glance
| Generic name | uric-acid-lowering drug |
|---|---|
| Sponsor | Huashan Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Remote Monitoring of Gout Feasibility Study in Primary Care (NA)
- An Exploratory Clinical Study on the Protective Effect of Cycling on the Ankle Joint in Gout (NA)
- Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout (PHASE1)
- Evaluation of Thyroid Function, Lipid Profile, and Uric Acid Levels in Hemodialysis Patients
- Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic Patients (PHASE2)
- The Remote Monitoring of Gout Study (NA)
- To Evaluate the Influence of (LUA Probiotics) on Uric Acid
- Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- uric-acid-lowering drug CI brief — competitive landscape report
- uric-acid-lowering drug updates RSS · CI watch RSS
- Huashan Hospital portfolio CI